clinical trial · NCT00071708
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Eli Lilly and Company·—·approved for marketing
Major Depressive DisorderFibromyalgiaDiabetic Peripheral Neuropathic PainGeneralized Anxiety DisorderDuloxetine Hydrochloride
brief summary
The primary objective of this study is to provide duloxetine to investigators for the treatment of patients who have previously participated in neuroscience duloxetine clinical trials and for whom effective alternative therapy is not available.
started
—
primary completion
—
completion
—
last updated
Jan 10, 2025
official title
Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol